Lisa Shieh1, Minjoung Go1, Daniel Gessner2, Jonathan H Chen3, Joseph Hopkins1, Paul Maggio4. 1. Department of Medicine, Stanford University School of Medicine, Stanford, California. 2. Department of Anesthesia, Brigham and Women's Hospital, Boston, Massachusetts. 3. Center for Innovation to Implementation (Ci2i), Veterans Affairs Palo Alto Health Care System, Palo Alto, California, and Center for Primary Care and Outcomes Research (PCOR), Stanford University, Stanford, California. 4. Department of Surgery, Stanford University School of Medicine, Stanford, California.
Abstract
BACKGROUND: The Agency for Healthcare Research and Quality has adopted iatrogenic pneumothorax (IAP) as a Patient Safety Indicator. In 2006, in response to a low performance ranking for IAP rate from the University Healthsystem Consortium (UHC), the authors established a multidisciplinary team to reduce our institution's IAP rate. Root-cause analysis found that subclavian insertion of central venous catheterization (CVC) was the most common procedure associated with IAP OBJECTIVE: Our short-term goal was a 50% reduction of both CVC-associated and all-cause IAP rates within 18 months, with long-term goals of sustained reduction. DESIGN: Observational study. SETTING: Academic tertiary care hospital. PATIENTS: Consecutive inpatients from 2006 to 2014. INTERVENTION: Our multifaceted intervention included: (1) clinical and documentation standards based on evidence, (2) cognitive aids, (3) simulation training, (4) purchase and deployment of ultrasound equipment, and (5) feedback to clinical services. MEASUREMENTS: CVC-associated IAP, all-cause IAP rate. RESULTS: We achieved both a short-term (years 2006 to 2008) and long-term (years 2006 to 2008-2014) reduction in our CVC-associated and all-cause IAP rates. Our short-term reduction in our CVC-associated IAP was 53% (P = 0.088), and our long-term reduction was 85% (P < 0.0001). Our short-term reduction in the all-cause IAP rate was 26% (P < 0.0001), and our long-term reduction was 61% (P < 0.0001). CONCLUSIONS: A multidisciplinary team, focused on evidence, patient safety, and standardization, can use a set of multifaceted interventions to sustainably improve patient outcomes for several years after implementation. Our hospital was in the highest performance UHC quartile for all-cause IAP in 2012 to 2014.
BACKGROUND: The Agency for Healthcare Research and Quality has adopted iatrogenic pneumothorax (IAP) as a Patient Safety Indicator. In 2006, in response to a low performance ranking for IAP rate from the University Healthsystem Consortium (UHC), the authors established a multidisciplinary team to reduce our institution's IAP rate. Root-cause analysis found that subclavian insertion of central venous catheterization (CVC) was the most common procedure associated with IAP OBJECTIVE: Our short-term goal was a 50% reduction of both CVC-associated and all-cause IAP rates within 18 months, with long-term goals of sustained reduction. DESIGN: Observational study. SETTING: Academic tertiary care hospital. PATIENTS: Consecutive inpatients from 2006 to 2014. INTERVENTION: Our multifaceted intervention included: (1) clinical and documentation standards based on evidence, (2) cognitive aids, (3) simulation training, (4) purchase and deployment of ultrasound equipment, and (5) feedback to clinical services. MEASUREMENTS: CVC-associated IAP, all-cause IAP rate. RESULTS: We achieved both a short-term (years 2006 to 2008) and long-term (years 2006 to 2008-2014) reduction in our CVC-associated and all-cause IAP rates. Our short-term reduction in our CVC-associated IAP was 53% (P = 0.088), and our long-term reduction was 85% (P < 0.0001). Our short-term reduction in the all-cause IAP rate was 26% (P < 0.0001), and our long-term reduction was 61% (P < 0.0001). CONCLUSIONS: A multidisciplinary team, focused on evidence, patient safety, and standardization, can use a set of multifaceted interventions to sustainably improve patient outcomes for several years after implementation. Our hospital was in the highest performance UHC quartile for all-cause IAP in 2012 to 2014.
Authors: Banafsheh Sadeghi; Ruth Baron; Patricia Zrelak; Garth H Utter; Jeffrey J Geppert; Daniel J Tancredi; Patrick S Romano Journal: Am J Med Qual Date: 2010 May-Jun Impact factor: 1.852
Authors: Hiroshi Sekiguchi; Joji Erik Tokita; Taro Minami; Lewis Ari Eisen; Paul Henry Mayo; Mangala Narasimhan Journal: Chest Date: 2011-06-09 Impact factor: 9.410
Authors: Haytham M A Kaafarani; Ann M Borzecki; Kamal M F Itani; Susan Loveland; Hillary J Mull; Kathleen Hickson; Sally Macdonald; Marlena Shin; Amy K Rosen Journal: J Am Coll Surg Date: 2010-12-14 Impact factor: 6.113
Authors: Irene W Y Ma; Mary E Brindle; Paul E Ronksley; Diane L Lorenzetti; Reg S Sauve; William A Ghali Journal: Acad Med Date: 2011-09 Impact factor: 6.893
Authors: Dimitrios Karakitsos; Nicolaos Labropoulos; Eric De Groot; Alexandros P Patrianakos; Gregorios Kouraklis; John Poularas; George Samonis; Dimosthenis A Tsoutsos; Manousos M Konstadoulakis; Andreas Karabinis Journal: Crit Care Date: 2006 Impact factor: 9.097
Authors: Rogerio da Hora Passos; Michel Ribeiro; Julio Neves; Joao Gabriel Rosa Ramos; Adelmo Vinicius Lima Oliveira; Zilma Barreto; Rosseane Ferreira; Conrado Gomes; Paulo Benigno Pena Batista; Jean Jacques Rouby Journal: Kidney Int Rep Date: 2017-04-07